Epidemiology: Incidence of glaucoma in the Handan Eye Study (23-2, April 2023) on:
104628 Five-year incidence of primary glaucoma and related risk factors - The Handan eye study
Zhang Y; Hao J; Zhang Q et al.
Acta Ophthalmologica 2022; 0:
Clinical Forms of Glaucoma: Glaucoma and Treated Diabetes (23-1, October 2022) on:
100638 Association of Diabetes Medication With Open-Angle Glaucoma, Age-Related Macular Degeneration, and Cataract in the Rotterdam Study
Vergroesen JE; Thee EF; Ahmadizar F et al.
JAMA ophthalmology 2022; 140: 674-681
Laser Treatment: SLT as First-Line Treatment: Patient and Treater Perspectives (22-4, July 2022) on:
98620 Facilitators and Barriers to Using Selective Laser Trabeculoplasty (SLT) as First-Line Treatment for Glaucoma: Physician and Patient Views Gathered during an Exploratory Descriptive Qualitative Study
Chen Y; Lohfeld L; Song D et al.
Ophthalmic Epidemiology 2022; 0: 1-8
Quality of Life: Glaucomatous Visual Impairement: What has changed in 40 years? (22-3, April 2022) on:
95788 Changes in incidence and severity of visual impairment due to glaucoma during 40 years - a register-based study in Finland
Vaajanen A; Purola P; Ojamo M et al.
Acta Ophthalmologica 2022; 100: 534-540
Miscellaneous: Global Burden of Glaucoma (21-1, November 2020) on:
84714 Socioeconomic disparities in the global burden of glaucoma: an analysis of trends from 1990 to 2016
Wu J; Yu X; Ping X et al.
Graefe's Archive for Clinical and Experimental Ophthalmology 2020; 258: 587-594
Surgical Treatment: What if it were you? (20-3, March 2020) on:
80960 Glaucoma surgery preferences when the surgeon adopts the role of the patient
Chang TC; Vanner EA; Parrish RK
Eye 2019; 33: 1577-1583
Surgical Treatment: Trends in Glaucoma Surgery (19-4, March 2019) on:
78029 Trends in Glaucoma Surgical Procedures in Portugal: A 16-Year Nationwide Study (2000-2015)
Barbosa-Breda J; Gonçalves-Pinho M; Santos JV et al.
Journal of Glaucoma 2018; 27: 682-686
Clinical Examination Methods: Function: Visual Field Progression (19-1, May 2018) on:
74502 Tolerable rates of visual field progression in a population-based sample of patients with glaucoma
Salonikiou A; Founti P; Kilintzis V et al.
British Journal of Ophthalmology 2018; 102: 916-921
Pharmacoeconomics: Changing Therapies Costs More (19-1, May 2018) on:
74248 Changing Initial Glaucoma Medical Therapy Increases Healthcare Resource Utilization
Trese MGJ; Lewis AW; Blachley TS et al.
Journal of Ocular Pharmacology and Therapeutics 2017; 33: 591-597
Glaucoma Screening: Screening High-Risk Populations (18-4, December 2017) on:
73164 Optimizing Glaucoma Screening in High-Risk Population: Design and 1-Year Findings of the Screening to Prevent (SToP) Glaucoma Study
Zhao D; Guallar E; Gajwani P et al.
American Journal of Ophthalmology 2017; 180: 18-28
Comment (18-2, April 2017) on:
70327 Effectiveness of early lens extraction for the treatment of primary angle-closure glaucoma (EAGLE): a randomised controlled trial
Azuara-Blanco A; Burr J; Ramsay C et al.
Lancet 2016; 388: 1389-1397
Risk Factors: Factors affecting IOP (17-3, June 2016) on:
66546 Associations with Intraocular Pressure in a Large Cohort: Results from the UK Biobank
Chan MP; Grossi CM; Khawaja AP et al.
Ophthalmology 2016; 123: 771-782
Glaucoma and Systemic Diseases: POAG and Glucose Metabolism Disorders (17-1, January 2016) on:
61623 Association of Geroprotective Effects of Metformin and Risk of Open-Angle Glaucoma in Persons With Diabetes Mellitus
Lin HC; Stein JD; Nan B et al.
JAMA ophthalmology 2015; 133: 915-923
Surgical treatment: Current trends in surgery (16-3, June 2015) on:
59097 Recent trends in glaucoma surgery in Scotland, England and Wales
Murphy C; Ogston S; Cobb C et al.
British Journal of Ophthalmology 2015; 99: 308-312
Epidemiology: Types of glaucoma in indigenous Africans (15-4, September 2014) on:
55212 Prevalence and types of glaucoma among an indigenous African population in southwestern Nigeria
Ashaye A; Ashaolu O; Komolafe O et al.
Investigative Ophthalmology and Visual Science 2013; 54: 7410-7416
Blindness Due to Glaucoma: Lifetime risk of blindness (15-3, May 2014) on:
54551 Lifetime risk of blindness in open-angle glaucoma
Peters D; Bengtsson B; Heijl A
American Journal of Ophthalmology 2013; 156: 724-730
Comments (14-1, November 2012) on:
49037 Cost-effectiveness of Medications Compared With Laser Trabeculoplasty in Patients With Newly Diagnosed Open-Angle Glaucoma
Stein JD; Kim DD; Peck WW et al.
Archives of Ophthalmology 2012; 130: 497-505
Heidelberg Retina Tomograph: Topographic change analysis (13-1, June 2011) on:
28025 Agreement between Heidelberg Retina Tomograph-I and-II in detecting glaucomatous changes using topographic change analysis
Balasubramanian M; Bowd C; Weinreb RN et al.
Eye 2011; 25: 31-42
Medical Treatment: Cataract and beta-blockers (11-3, December 2009) on:
24141 Use of antihypertensive medications and topical beta-blockers and the long-term incidence of cataract and cataract surgery
Kanthan GL; Wang JJ; Rochtchina E et al.
British Journal of Ophthalmology 2009; 93: 1210-1214
IOP, VF, Imaging and Electrophysiology: IOP in upgaze (10-4, March 2009) on:
22344 Is gaze-dependent tonometry a useful tool in the differential diagnosis of Graves' ophthalmopathy?
Herzog D; Hoffmann R; Schmidtmann I et al.
Graefe's Archive for Clinical and Experimental Ophthalmology 2008; 246: 1737-1741